During the last session, Medical Properties Trust Inc (NYSE:MPW)’s traded shares were 13.79 million, with the beta value of the company hitting 1.35. At the end of the trading day, the stock’s price was $4.57, reflecting an intraday gain of 5.30% or $0.23. The 52-week high for the MPW share is $6.55, that puts it down -43.33 from that peak though still a striking 32.6% gain since the share price plummeted to a 52-week low of $3.08. The company’s market capitalization is $2.74B, and the average intraday trading volume over the past 10 days was 14.69 million shares, and the average trade volume was 12.47 million shares over the past three months.

Medical Properties Trust Inc (MPW) received a consensus recommendation of Hold from analysts. That translates to a mean rating of 3.45. MPW has a Sell rating from 1 analyst(s) out of 9 analysts who have looked at this stock. 5 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 3 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 0.1.

Medical Properties Trust Inc (NYSE:MPW) trade information

Medical Properties Trust Inc (MPW) registered a 5.30% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 5.30% in intraday trading to $4.57, hitting a weekly high. The stock’s 5-day price performance is 10.65%, and it has moved by 21.54% in 30 days. Based on these gigs, the overall price performance for the year is 41.05%. The short interest in Medical Properties Trust Inc (NYSE:MPW) is 230.24 million shares and it means that shorts have 17.51 day(s) to cover.

The consensus price target of analysts on Wall Street is $6.75, which implies an increase of 32.3% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $6 and $7.5 respectively. As a result, MPW is trading at a discount of -64.11% off the target high and -31.29% off the low.

Medical Properties Trust Inc (MPW) estimates and forecasts

Statistics show that Medical Properties Trust Inc has underperformed its competitors in share price, compared to the industry in which it operates. Medical Properties Trust Inc (MPW) shares have gone down -8.05% during the last six months, with a year-to-date growth rate less than the industry average at -50.94% against -3.60. In the rating firms’ projections, revenue will increase 12.88% compared to the previous financial year.

As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 218.92M as predicted by 7 analyst(s). Meanwhile, a consensus of 5 analyst(s) estimates revenue growth to 225.39M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled -122.38M and 271.32M respectively. In this case, analysts expect current quarter sales to grow by 278.88% and then drop by -16.93% in the coming quarter.

While earnings are projected to return -240.61% in 2025, the next five years will return 12.00% per annum.

MPW Dividends

Medical Properties Trust Inc is due to release its next quarterly earnings in February. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance. Investors should also take the other fundamental and operational aspects into account before investing in the stock. The forward dividend ratio for Medical Properties Trust Inc is 0.46, with the dividend yield indicating at 10.07 percent, continuing the trend of increasing dividends in recent years. The average dividend yield of the company for the last 5 years is 9.67%.

Medical Properties Trust Inc (NYSE:MPW)’s Major holders

Medical Properties Trust Inc insiders own 13.36% of total outstanding shares while institutional holders control 65.55%, with the float percentage being 75.66%. BLACKROCK INC. is the largest shareholder of the company, while 655.0 institutions own stock in it. As of 2024-06-30, the company held over 92.15 million shares (or 15.3511% of all shares), a total value of $397.18 million in shares.

The next largest institutional holding, with 92.1 million shares, is of VANGUARD GROUP INC’s that is approximately 15.3429% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $396.97 million.